Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval
This historic approval of the world s first Self-Amplifying messenger RNA COVID-19 Vaccine underscores CSL s promise to.
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' (ARCT) ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Arcturus Therapeutics (ARCT) Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
First cystic fibrosis patient in Phase 1b study successfully completed two administrations of ARCT-032
On track to share interim Phase 1b data in H1 2024
.
Arcturus: COVID Vaccine Approval Shots In Japan And Europe Key To Unlocking Upside (NASDAQ:ARCT) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.